Prevalence of current tobacco use (% of adults) in Libya
Libya: Prevalence of current tobacco use (% of adults) was 24.2% in 2024. ▼ Falling
Prevalence of current tobacco use in Libya, 2000–2024
Source: Global Health Observatory Data Repository, World Health Organization (WHO). Measured in % of adults.
Analysis
The most recent figure for prevalence of current tobacco use in Libya is 24.2%, measured in 2024. That is the lowest value across all 9 years on record.
Compared with earlier readings it is down 1.2% on the previous year and down 11.7% over ten years.
Over the whole period, prevalence of current tobacco use in Libya peaked at 34.4% in 2000 and was at its lowest, 24.2%, in 2024.
Libya ranks 53rd of 166 countries on this measure, in the middle of the range.
Prevalence of current tobacco use (% of adults) in Libya, year by year
| Year | % of adults | Change |
|---|---|---|
| 2000 | 34.4% | — |
| 2005 | 32.0% | -7.0% |
| 2007 | 31.0% | -3.1% |
| 2010 | 29.6% | -4.5% |
| 2015 | 27.4% | -7.4% |
| 2020 | 25.6% | -6.6% |
| 2022 | 24.8% | -3.1% |
| 2023 | 24.5% | -1.2% |
| 2024 | 24.2% | -1.2% |
Libya compared with similar countries
- Libya's 24.2% is above the median for upper middle income countries, which is 21.1%, 1.1× the median. (51 countries reporting)
- Libya's 24.2% is above the median for Middle East, North Africa, Afghanistan & Pakistan, which is 20.6%, 1.2× the median. (20 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 32.5% | 31.0% | 34.4% | 3 |
| 2010s | 28.5% | 27.4% | 29.6% | 2 |
| 2020s | 24.8% | 24.2% | 25.6% | 4 |
Countries ranked near Libya
More health data for Libya
- Un projection of annual infant deaths, annual growth rate -1.48 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 1.1 % change on previous year (2090)
- Un projection of annual infant deaths 133 (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2024)
- Population ages 00-04, female, annual growth rate -1.83 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0404 units per person (2025)
- Population ages 00-04, male, annual growth rate -1.77 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, male, per capita 0.0427 units per person (2025)
Frequently asked questions
- What is prevalence of current tobacco use in Libya?
- Prevalence of current tobacco use in Libya was 24.2% in 2024, according to Global Health Observatory Data Repository, World Health Organization (WHO).
- What is the highest prevalence of current tobacco use recorded in Libya?
- The highest recorded value was 34.4% in 2000.
- What is the lowest prevalence of current tobacco use recorded in Libya?
- The lowest recorded value was 24.2% in 2024.
- How does Libya rank for prevalence of current tobacco use?
- Libya ranks 53rd out of 166 countries with data for 2024.
- Is prevalence of current tobacco use rising or falling in Libya?
- Over the last ten years it is down 11.7%. The long-run trend across the full record is falling.
- Where does this Libya data come from?
- The figures come from Global Health Observatory Data Repository, World Health Organization (WHO), published as part of Prevalence of current tobacco use (% of adults). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 9 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of the population ages 15 years and over who currently use any tobacco product (smoked and/or smokeless tobacco) on a daily or non-daily basis. Tobacco products include cigarettes, pipes, cigars, cigarillos, waterpipes (hookah, shisha), bidis, kretek, heated tobacco products, and all forms of smokeless (oral and nasal) tobacco. Tobacco products exclude e-cigarettes (which do not contain tobacco), “e-cigars”, “e-hookahs”, JUUL and “e-pipes”. The rates are age-standardized to the WHO Standard Population.